Login / Signup
Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".
Mariam O Fofana
D W Dowdy
Published in:
Antimicrobial agents and chemotherapy (2017)
Keyphrases
</>
multidrug resistant
mycobacterium tuberculosis
drug resistant
pulmonary tuberculosis
emergency department
acinetobacter baumannii
escherichia coli
hiv aids
combination therapy
pseudomonas aeruginosa
hiv infected
human immunodeficiency virus
replacement therapy
insulin resistance
antiretroviral therapy
weight loss